Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 71, Issue 2, 2011, Pages 145-149

  Grubb, Anders ^a   Björk, Jonas ^a   Nyman, Ulf ^b   Pollak, Joanna ^a,c   Bengzon, Johan ^a   Östner, Gustav ^a   Lindström, Veronica ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Cardiovascular disease; kidney function; surgery

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; CYSTATIN C; HAPTOGLOBIN; OROSOMUCOID; SERUM AMYLOID A;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; ELECTIVE SURGERY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREND STUDY;

AGING; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CREATININE; CYSTATIN C; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; SERUM AMYLOID A PROTEIN;

EID: 79952428528     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2010.546879     Document Type: Article

References (27)

1. Shlipak MG, Sarnak MJ, Katz R, Fried LF, Seliger SL, Newman AB, Siscovick DS, Stehman-Breen C. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 2005;352:2049-60. (Pubitemid 40664306)
2. Stevens LA, Levey AS. Chronic kidney disease in the elderly-how to assess risk. N Engl J Med 2005;352:2122-4. (Pubitemid 40664314)
3. Zethelius B, Berglund L, Sundström J, Ingelsson E, Basu S, Larsson A, Venge P, Ärnlöv J. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008;358:2107-16. (Pubitemid 351679597)
4. Sarnak MJ, Katz R, Fried LF, Siscovick D, Kestenbaum B, Seliger S, Rifkin D, Tracy R, Newman AB, Shlipak MG. Cystatin C and aging success. Arch Intern Med 2008;168:147-53. (Pubitemid 351192910)
5. Taglieri N, Koenig W, Kaski JC. Cystatin C and cardiovas-cular risk. Clin Chem 2009;55:1932-43.
6. Jernberg T, Lindahl B, James S, Larsson A, Hansson LO, Wallentin L. Cystatin C: a novel predictor of outcome in suspected or confirmed non-ST-elevation acute coronary syndrome. Circulation 2004;110:2342-8. (Pubitemid 39407337)
7. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006;354:2473-83. (Pubitemid 43855050)
8. Rifkin DE, Katz R, Chonchol M, Fried LF, Cao J, deBoer IH, Siscovick DS, Shlipak MG, Sarnak MJ. Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly. Nephrol Dial Transplant 2010;25:1560-7.
9. Perkins BA, Nelson RG, Krolewski AS. Cystatin C and the risk of death. N Engl J Med 2005;353:843.
10. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem 2005;51:321-7. (Pubitemid 40175801)
11. Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG. Associa-tion of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul study. Nephrol Dial Trans-plant 2007;22:1087-92. (Pubitemid 46523422)
12. Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG. Kidney function and markers of inflamma-tion in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int 2007;71:239-44. (Pubitemid 46160924)
13. Knight EL, Verhave JC, Spiegelman D, Hillege HL, deZeeuw D, Curhan GC, deJong PE. Factors influencing cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 2004;65:1416-21. (Pubitemid 38406982)
14. Dati F, Schumann G, Thomas L, Aguzzi F, Baudner S, Bienvenu J, Blaabjerg O, Blirup-Jensen S, Carlström A, Hyltoft-Petersen P, Johnson AM, Milfor-Ward A, Ritchie R, Just Svendsen P, Whicher J. Consensus of a group of professional societies and diagnostic companies on guide-lines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP reference material (CRM 470). Eur J Clin Chem Clin Biochem 1996;34:517-20.
15. Hutchinson WL, Koenig W, Fröhlich M, Sund M, Lowe GDO, Pepys MB. Immunoradiometric assay of circulating C-reactive protein: age-related values in the adult general population. Clin Chem 2000;46:934-8. (Pubitemid 30461263)
16. Kyhse-Andersen J, Schmidt C, Nordin G, Andersson B, Nilsson-Ehle P, Lindström V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced tur-bidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 1994;40:1921-6.
17. Norlund L, Fex G, Lanke J, von Schenck H, Nilsson JE, Leksell H, Grubb A. Reference intervals for the glomerular filtration and cell-proliferation markers: serum cystatin C and serum beta-2-microglobulin/cystatin C ratio. Scand J Clin Lab Invest 1997;57:463-70. (Pubitemid 27443517)
18. Rothkrantz-Kos S, Schmitz MP, van Dieijen-Visser MP. Ana-lytical evaluation and reference values of serum amyloid-A on the BN ProSpec. Clin Chem Lab Med 2004;42:973-5.
19. Poole S, Walker D, Gaines Das RE, Gallimore JR, Pepys MB. The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study. J Immunol Methods 1998;214:1-10. (Pubitemid 28335533)
20. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW van Lente F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-54. (Pubitemid 46768608)
21. Pottel H, Vrydags N, Mahieu B, Vandewynckele E, Croes K, Martens F. Establishing age/sex related serum creati-nine reference intervals from hospital laboratory data based on different statistical methods. Clin Chim Acta 2008;396:49-55.
22. Grubb A. Non-invasive estimation of glomerular filtration rate (GFR). The Lund model: simultaneous use of cystatin C-and creatinine-based GFR-prediction equations, clinical data and an internal quality check. Scand J Clin Lab Invest 2010;70:65-70.
23. Grubb A, Lindström V, Kristensen K, Christensson A, Wide-Swensson D, Strevens H, Schmidt C, Blirup-Jensen S. Fil-tration quality: a new measure of renal disease. Clin Chem Lab Med 2007;45:(Suppl. S2):73-4.
24. Strevens H, Wide-Swensson D, Torffvit O, Grubb A. Serum cystatin C for assessment of glomerular filtration rate in pregnant and non-pregnant women. Indications of altered filtration process in pregnancy. Scand J Clin Lab Invest 2002;62:141-8.
25. Roberts M, Lindheimer MD, Davison JM. Altered glomeru-lar permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy. Am J Physiol 1996;270:F338-43.
26. Okura T, Jotoku M, Irita J, Enomoto D, Nagao T, Desilva VR, Yamane S, Pei Z, Kojima S, Hamano Y, Mashiba S, Kurata M, Miyoshi K, Higaki J. Association between cystatin C and inflammation in patients with essential hypertension. Clin Exp Nephrol 2010;14:358-63.
27. Al-Maliki N, Heidenheim PA, Filler G, Yasin A, Lindsay RM. Cystatin C levels in functionally anephric patients undergoing dialysis: the effect of different methods and intensities. Clin J Am Soc Nephrol 2009;4:1606-10.